ArticleInternational journal of pharmaceutics: X2025

Developing Immunoniosomes (INs): Antibody and Fab conjugations of niosomal nanoparticles via UV-NBS and EDC/NHS chemistry for treating glioblastoma cells.

Nilufer Cakir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.